AVITA Medical Issues 387,716 Shares To Lender Perceptive After Warrant Exercise

Perceptive Credit Holdings V used a cashless exercise on a warrant for up to 500,000 shares, and the company withheld 112,284 shares.

Share
AVITA Medical Issues 387,716 Shares To Lender Perceptive After Warrant Exercise

AVITA Medical, which sells the RECELL skin-cell spray device for burns and wounds, issued 387,716 shares of common stock to its lender, Perceptive Credit Holdings V, after the lender exercised a warrant on a cashless basis, according to an 8-K filed Monday.

How the cashless exercise worked

Perceptive exercised the warrant on October 26, 2026. The warrant covered up to 500,000 shares of AVITA common stock.

Instead of paying cash for the exercise price, Perceptive had the company hold back 112,284 shares covered by the warrant. AVITA issued the remaining 387,716 shares to Perceptive on October 28, 2026.

The company said it lodged filings about the exercise on the Australian Securities Exchange on Monday, as that exchange's listing rules require. The 8-K furnishes that notice to the SEC under Regulation FD, the rule governing how companies share material information with investors.

A warrant born of the credit agreement

The warrant certificate was issued to Perceptive on June 5, 2026. It was issued under a Credit Agreement and Guaranty between Perceptive and AVITA dated January 13, 2026, which the company said it had previously disclosed.

The lender has now turned that instrument into stock, and the shares issued to it are 387,716 rather than the full 500,000.

The company behind the shares

AVITA is an acute wound care company serving U.S. burn, trauma and surgical centers. Its RECELL device lets clinicians make a spray of a patient's own skin cells at the point of care. It also sells PermeaDerm, a biosynthetic wound matrix, and Cohealyx, a collagen-based dermal matrix.

The company makes RECELL and PermeaDerm at its Ventura, California plant. Its common stock trades on Nasdaq under the symbol RCEL.

The Perceptive warrant was exercisable for up to 500,000 shares, and 387,716 of them reached the lender on October 28, 2026.

Sources